How to Invest in DeepSeek Pre-IPO
You can't currently use an exchange-traded fund (ETF) to gain passive exposure to DeepSeek because it's not a publicly traded ...
OpenAI Alleges DeepSeek Used Proprietary Models Without Permission As Microsoft Investigates AI Security Risks: 'There's Substantial Evidence'
OpenAI announced it has uncovered evidence that Chinese artificial intelligence startup DeepSeek allegedly used its ...
Tentative IPO Rebound Threatened by DeepSeek-Fueled Volatility
When US tech stocks were crushed by the emergence of DeepSeek this week, already-cautious investors found one more reason to ...
Forbes Daily: DeepSeek’s ‘Wake-Up Call’ And Nvidia’s Historic Plunge
Tuesday's Forbes Daily covers Chinese AI DeepSeek's impact on stock market, Boeing's earnings woes, Trump's military orders, ...
Zacks.com on MSN1d
HOOD Falls From All-Time High on DeepSeek Turbulence: Buy the Dip?
The recent market sell-off over DeepSeek has put pressure on many stocks, including Robinhood. Does this dip present a smart ...
Lenskart plans $1 billion IPO, hiring Kotak Mahindra and Morgan Stanley: Report
Lenskart may seek a valuation of $8 billion and other banks may also join to work on the IPO, but considerations are ongoing ...
Jim Cramer Squashes DeepSeek Hype, Warns Of AI 'Sputnik Moment' Amid Investor Frenzy And US-China 'Inferiority Complex'
CNBC's Jim Cramer in his latest X post alluded to the Chinese artificial intelligence startup DeepSeek's hype and sneered at ...
Not Just DeepSeek - Alibaba Unveils AI Model To Rival OpenAI's Operator
Chinese e-commerce juggernaut Alibaba Group Holding’s (NYSE:BABA) cloud unit released a new family of AI models, Qwen2.5-VL, ...
Biotech firm Maze Therapeutics raises $140 million in US IPO
Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that could make the kidney disease drug developer the first U.S. biotech ...